NuPhase Therapeutics
PrivateLast Round
Early Funding
Feb 24, 2025
Total Funding Raised
$4.13M
Company Overview
NuPhase Therapeutics is a biotechnology company that focuses on drug discovery by leveraging proprietary liquid-liquid phase separation and high-throughput drug screening platforms to develop targeted therapies for challenging diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuPhase Therapeutics Comparables
Compare NuPhase Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arrakis Therapeutics | 81% | |
| Twentyeight-Seven Therapeutics | 77% | |
| Transition Bio | 70% |
NuPhase Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 24, 2025 | ||||
| Seed | Nov 28, 2024 |
NuPhase Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Seed |
| Proxima Ventures Ltd. | Seed, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2024
Seed round raised with participation from Nest.Bio and Proxima Ventures.
NuPhase Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NuPhase Therapeutics's valuation, stock price, and market status.
Is NuPhase Therapeutics a public or private company?
NuPhase Therapeutics is a private company.
What is the current stock price of NuPhase Therapeutics?
NuPhase Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is NuPhase Therapeutics worth (valuation)?
Valuation information for NuPhase Therapeutics is not publicly available.
Can I buy NuPhase Therapeutics stock?
NuPhase Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NuPhase Therapeutics's last funding round?
NuPhase Therapeutics's most recent funding round was Early Funding on February 24, 2025.
Who are the main investors in NuPhase Therapeutics?
Key investors in NuPhase Therapeutics include Nest Bio Ventures, Proxima Ventures Ltd..
Will NuPhase Therapeutics IPO soon?
No public IPO plans have been announced for NuPhase Therapeutics.
How can I track NuPhase Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NuPhase Therapeutics's secondary market activity and sign up for updates.